Merck gives Moderna $ 250 million for cancer mRNA vaccine
The pharmaceutical company could "cash in" on the mRNA cancer vaccine it is helping to create.
The pharmaceutical company could "cash in" on the mRNA cancer vaccine it is helping to create.
It's called Molnupiravir and for days we've been talking about nothing other than this antiviral that can help us deal a perhaps decisive blow to Covid. But how does it work?
Moderna and Merck's vaccine reduces melanoma death rate by 62%, moving closer to FDA approval in 2025
Future of Cryptography: Preparing for the quantum era and the new frontiers of data security.
Death is the end of everything. Our brain, which has functioned well for many decades, at the moment of our departure from the world, in the space of just twenty minutes undergoes anoxia and neurons and synapses fall apart. No machine, after such damage, will be able to revive us; it will be able to reactivate cardiac functions and circulation but our brain will be gone forever. And to say that the brain has "gone" for philosophy... Read more